Triethylamine → N-[(2S,6R)-4-(Cyclopropylmethyl)-5-oxo-2-phenyl-1,4-oxazepan-6-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide

HRID 1366022

反応式

HRID 1366022 の反応式
C(N(CC)CC)C.[NH2:8][C@@H:9]1[CH2:15][O:14][C@@H:13]([C:16]2[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=2)[CH2:12][N:11]([CH2:22][CH:23]2[CH2:25][CH2:24]2)[C:10]1=[O:26].Cl[C:28](OC1C=CC([N+]([O-])=O)=CC=1)=[O:29].C(N(C(C)C)CC)(C)C.Cl.Cl.[O:51]=[C:52]1[NH:60][C:55]2=[N:56][CH:57]=[CH:58][CH:59]=[C:54]2[N:53]1[CH:61]1[CH2:66][CH2:65][NH:64][CH2:63][CH2:62]1>O1CCCC1.ClCCl>[CH:23]1([CH2:22][N:11]2[C:10](=[O:26])[C@H:9]([NH:8][C:28]([N:64]3[CH2:65][CH2:66][CH:61]([N:53]4[C:54]5[C:55](=[N:56][CH:57]=[CH:58][CH:59]=5)[NH:60][C:52]4=[O:51])[CH2:62][CH2:63]3)=[O:29])[CH2:15][O:14][C@@H:13]([C:16]3[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=3)[CH2:12]2)[CH2:25][CH2:24]1

参加物

8

実験手順

Triethylamine (0.015 mL, 0.109 mmol) was added to a solution of (2S,6R)-6-amino-4-(cyclopropylmethyl)-2-phenyl-1,4-oxazepan-5-one (27 mg, 0.104 mmol) and 4-nitrophenyl chloroformate (22 mg, 0.109 mmol) in tetrahydrofuran (2 mL) at 0° C. After 0.5 h, diisopropylethylamine (0.072 mL, 0.415 mmol), 2-oxo-1-(4-piperidinyl)-2,3-dihydro-1H-imidazo[4,5-b]pyridine dihydrochloride (36 mg, 0.124 mmol), and dichloromethane (2.5 mL) were added and the mixture warmed to ambient temperature. After 18 h, the mixture was concentrated. Purification by silca gel chromatography (100% dichloromethane→95% dichloromethane/methanol) gave the title compound (45 mg). MS 505.2559 (M+1).

後処理

  1. waitAfter 18 h
  2. concentrationthe mixture was concentrated
  3. customPurification by silca gel chromatography (100% dichloromethane→95% dichloromethane/methanol)

出典と根拠

ORDレコード
ord-e9140cfb51a0445cabac3e5660401dc2
出典データセット
uspto-grants-2011_02
特許番号
US07893052B2

関連ノート

読み込み中…